About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00599768

Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese...

Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female.
•Subjects who are able to complete the ID Pain-T Questionnaire.

Exclusion Criteria

•Subjects who are illiterate or unable to complete questionnaire.
•Subjects who are currently participating in another study or have participated in another pain study within one month of study entry.
•Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).

Related studies

RECRUITINGPhase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

NCT07231419 · Diabetic Peripheral Neuropathic Pain

RECRUITINGPhase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more

RECRUITINGPhase 2

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more

Neuropathic Characteristics of Subacromial Pain Syndrome

NCT07057128 · Neuropathic Pain, Central Sensitization, and more

Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis

NCT07493226 · Frozen Shoulder, Adhesive Capsulitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 22, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment325

Start dateMar 2008

Last updatedJan 22, 2021

Condition

Neuralgia Nerve Pain Neuropathic Pain

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 22, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions